Blimp-1 homolog Hobit identifies effector-type lymphocytes in humans
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blimp-1 homolog Hobit identifies effector-type lymphocytes in humans
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 45, Issue 10, Pages 2945-2958
Publisher
Wiley
Online
2015-07-15
DOI
10.1002/eji.201545650
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blimp-1 Attenuates Th1 Differentiation by Repression of ifng, tbx21, and bcl6 Gene Expression
- (2014) L. Cimmino et al. JOURNAL OF IMMUNOLOGY
- The Prdm family: expanding roles in stem cells and development
- (2012) T. Hohenauer et al. DEVELOPMENT
- Cytometry by Time-of-Flight Shows Combinatorial Cytokine Expression and Virus-Specific Cell Niches within a Continuum of CD8+ T Cell Phenotypes
- (2012) Evan W. Newell et al. IMMUNITY
- Mouse Hobit is a homolog of the transcriptional repressor Blimp-1 that regulates NKT cell effector differentiation
- (2012) Klaas P J M van Gisbergen et al. NATURE IMMUNOLOGY
- Progenitor and Terminal Subsets of CD8+ T Cells Cooperate to Contain Chronic Viral Infection
- (2012) M. A. Paley et al. SCIENCE
- Human virus-specific effector-type T cells accumulate in blood but not in lymph nodes
- (2011) E. B. M. Remmerswaal et al. BLOOD
- An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells
- (2011) Weiguo Cui et al. IMMUNITY
- Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells
- (2011) Yun Ji et al. NATURE IMMUNOLOGY
- The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets
- (2011) Cliff Y Yang et al. NATURE IMMUNOLOGY
- The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells
- (2011) Erika Cretney et al. NATURE IMMUNOLOGY
- A role for Blimp1 in the transcriptional network controlling natural killer cell maturation
- (2010) A. Kallies et al. BLOOD
- Differentiation and Persistence of Memory CD8+ T Cells Depend on T Cell Factor 1
- (2010) Xinyuan Zhou et al. IMMUNITY
- Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation
- (2010) Kirsten M.L. Hertoghs et al. JOURNAL OF CLINICAL INVESTIGATION
- One naive T cell, multiple fates in CD8+T cell differentiation
- (2010) Carmen Gerlach et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PRDM1/Blimp-1 Controls Effector Cytokine Production in Human NK Cells
- (2010) M. A. Smith et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: The Transcription Factor Eomesodermin Enables CD8+ T Cells To Compete for the Memory Cell Niche
- (2010) A. Banerjee et al. JOURNAL OF IMMUNOLOGY
- Raising the NKT cell family
- (2010) Dale I Godfrey et al. NATURE IMMUNOLOGY
- An extended set of PRDM1/BLIMP1 target genes links binding motif type to dynamic repression
- (2010) Gina M. Doody et al. NUCLEIC ACIDS RESEARCH
- KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells
- (2009) S. M. Henson et al. BLOOD
- Transcriptional Repressor Blimp-1 Promotes CD8+ T Cell Terminal Differentiation and Represses the Acquisition of Central Memory T Cell Properties
- (2009) Rachel L. Rutishauser et al. IMMUNITY
- Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses
- (2009) Axel Kallies et al. IMMUNITY
- A Role for the Transcriptional Repressor Blimp-1 in CD8+ T Cell Exhaustion during Chronic Viral Infection
- (2009) Haina Shin et al. IMMUNITY
- Memory Inflation during Chronic Viral Infection Is Maintained by Continuous Production of Short-Lived, Functional T Cells
- (2008) Christopher M. Snyder et al. IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started